A clinical trial explores the safety and efficacy of low-intensity shockwave therapy (LiSWT) as a treatment option for people suffering from erectile dysfunction.
Erectile dysfunction (ED) is a common problem affecting many men worldwide. It is a condition that makes it difficult for men to maintain an erection during sexual activity. The causes of ED can be physical or psychological, and it can be a source of frustration and embarrassment for many men.
In recent years, low-intensity shockwave therapy (LiSWT) has emerged as a potential treatment for vasculogenic ED. LiSWT involves using low-intensity shockwaves to stimulate the growth of new blood vessels in the penis, improving blood flow and helping to achieve and maintain an erection. However, well-designed clinical trials justifying its use in vasculogenic ED were lacking.
To correct this, a clinical trial was conducted that examined the early outcomes of a short course of LiSWT for patients suffering from ED.
Clinical TrialThe trial included 51 men aged 18 years or older with erectile dysfunction symptoms present for at least 1 month. The men were divided into two groups: the treatment group, which received LiSWT, and the control group, which received a sham treatment. The treatment group received a total of 4 LiSWT sessions over the course of 4 weeks, while the control group did not.
The patients were re-assessed at 1, 3, and 6 months post-therapy. The International Index of Erectile Function-5 and Erection Hardness Score (EHS) questionnaires were used for the evaluation of ED.